Unraveling hepatitis B virus infection of mice and men (and woodchucks and ducks)

Nature Medicine

Volumn 5, Issue 10, 1999, Pages 1125-1126

  Menne, Stephan ^a   Tennant, Bud C ^a  

^a Department of Population Medicine and Diagnostic Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; CHRONIC HEPATITIS; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DUCK; HEPATITIS B; IMMUNOPATHOGENESIS; INTERFERON PRODUCTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE ACTIVATION; VIRUS CELL INTERACTION; VIRUS INHIBITION; WOODCHUCK;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CYTOKINES; DISEASE MODELS, ANIMAL; DUCKS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MARMOTA; MICE; MICE, TRANSGENIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032826033     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/13445     Document Type: Short Survey

References (14)

1. Chang, K-M., & Chisari, F.V. Immuno-pathogenesis of hepatitis B virus infection. Clin. Liver Dis. 3, 221-239 (1999).
2. Chisari, F.V., & Ferrari, C. In: Viral pathogenesis (ed., Nathanson, N.) 745-778 (Lippincot-Raven, Philadelphia, 1997).
3. Tennant, B.C. Animal models of hepatitis B virus infection. Clin. Liver Dis. 3, 241-266 (1999).
4. Vickery, K., Cossart, Y., & Dixon R. Cellular immune response of ducks to duck hepatitis B virus infection. J. Med. Virol. 58, 19-25 (1999).
5. Menne, S., Maschke, J., Lu, M., Grosse-Wilde, H., & Roggendorf, M. T-cell response to woodchuck hepatitis virus (WHV) antigens during acute self-limited WHV infection and convalescence and after viral challenge. J. Virol. 72, 6083-6091 (1998).
6. Chisari, F.V. Hepatitis B virus transgenic mice: Models of viral immunobiology and pathogenesis. Curr. Top. Microbiol. 206, 150-173 (1996).
7. Larkin, J. et al. Hepatitis B virus transgenic SCID mouse model of chronic liver disease. Nature Med. 5, 907-912 (1999).
8. Guidotti, L.C. et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity, 25-36 (1996).
9. Guidotti, L.G. et al. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA. 91, 3764-3768 (1994).
10. Guidotti, L.C. et al. Viral clearance without destruction of infected cells during acute HBV infection. Science 284, 25-29 (1999).
11. Krogsgaard, K. et al. The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep). J. Hepatol. 21, 646-655 (1994).
12. Dienstag, J.L et al. A preliminary trial of lamivudine for chronic hepatitis B infection. N. Engl. J. Med. 333, 1657-1661 (1995).
13. Pol, S. et al. Immunotherapy of chronic hepatitis B by anti HBV vaccine. Acta. Castroenterol. Belg. 61, 228-233 (1998).
14. Heathcote, J. et al. A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. Hepatology 30, 531-536 (1999).